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logic blood plopertlas 8s indicated by plasma fibnnogen levels (FIB) and left 
ventrieular (LV) function after myocardial infarction (MI) remain underlain. 
Met t '~:  92 patients (pta) with proven anterior MI were investigated. NO 
inten~ntlonal or thrombolylic therapy was performed. Inclusion cntena were: 
1. Ilmtatad proximal occlusion of the kPft amOrlOr descending arfery (LAD) :,3 
weeks af1~ MI. 2, Remaining corona~/allerles and corresl:~Ondtng LV wall 
segmenl~ ~m nom~l. PI~. were ~ into 4 gro~ (gr.): 
gro~e PAP (~1 ~k)  F~B 
Re~lmfl~; Tbe 4 gr, were o:~mpafable regarding age, gender, age el MI and 
nsk fe¢toe~ Pts. m gf. 3 and 4 ~ more frequent ACE inh~bitom than gr. 
1 and 2 pts. LV eiect~ fraction (EF) deemase~ and the number 0! akinet~ 
~ ! S  (aS) ~.vea~ed from gr. ~ to4~ 
group l 2 3 4 
FIB (~)  2~03 ,tOt O" 2885 4187" 
(%) 6o.0 SO.a" S3:' ~. t "  
AS (%) S,~8 a3.a-- ~.7 ~.5-- 
2 p ~ O0~, g~. !~4:  p < O00~ 
Conci~u~: PAP has e ~ ~leet on ~ LV.func~on after ~qten(~" 
MI d~to  I ~  oedlJ~on of the L~D, I ~  by #~ d e ~  
of o~,)ary collatera~. This is a~,~ed by u~avomabee meofo~c blood 
i-..~p~,i:4is as indicated by ~ FiB ~ s .  Pts. without PAP and 
elevated FiB levets m at I ~  dsk for a targe MI and reduced LV-functon. 
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11004-1311 An~iotensin Converting Enzyme Inhibitor 
CaptopHI Does not  Improve Emrdse  Tolerance 
or  Reduce Exercise Induced Myocardial  
Ischemia in Patients With Anoina Pec lods  
U. Thadani, N. B~ar. Urmmrsil), of Oldahoma, Oklahoma Cd~. OK. USA 
Angiotensin is a potent coronary vasoconstnctor but reported effects of con- 
vetting enzyme inhib~Drs On exercise reduced myocardial ischemia am con- 
flicting. In a double-blind, ral~0mized crossover study, effects of ~ing~e oral 
doses of placebo, Captoprt| (CAPT) 25 mg and CAPT SO mg were eve~u- 
ated in 15 patients wdh exercise induced angina assemated with __.1 mm ST 
depmssioe. All antianginal o~ugs were discontinued and patmnts performed 
symptom limited treadmill exercise tests on 3 separate days before and I a~l 
4 hours after the administrations of the study drug. Compared to pre-drug 
baseline values, mean changes in seconds at t and 4 hours (h) post~Jose 
for various exercise variables were: 
Placebo CAPT 25 mg .... CAPT 25 mg 
th 4h lh  411 lh  4h 
Time to Angina +20 +5 + 1 - 6 +6 - 1 
Total Exerc-"~e "~me +1 -4 +8 -6 *6 -8 
"i~me tO t •rn ST ~ +8 -1 +14 +26 +21 +7 
Data show lack of improvement in exercise times or p.'olongation of time 
to myocardial ischemia after the two doses of CAPT compared to placebo. 
Above results were confirmed in another group of 27 patients who received 
CAPT 25 mg tid for 2 weeks followed by CAPT 50 mg tid for 4 weeks. These 
results suggest lhat CAPT does not exert any antianginal or anti-ischemic 
effects in patients with exercise induced angina. 
1004-1321 Angiotens in  II Receptor Antagonism Does Not 
Prevent Tolerance to Cont inuous Transdermal 
Nitroglycerin 
S.D. Milone, E.R. Azevedo, A.B. Parker, C. Forster, J.D. Parker. Universi~ 
of Toronto, Canada 
Background: Animal data suggests that nitrate tolerance may be caused by 
increased supemxtde an~ preduct~ and may be prevented w~ an ang~o, 
tensin II receptor (ATo antagar, st. We teared the h vpothas=s that tt~wapy 
with the ATt antagonist Lossflan wo~ld prevent he (~elopm~t of romance 
to cominuoua trfnsdermat nitr0glyeenn (TGTN) in humans. 
Method: Twemy normal mato vofur~e~m rece~ve~ Losa~an 75 rn~0ay 
or placebo in a ~ e ~ ,  double t~ind, pare, el ~ ,  A~,  I 
contlmmus TGTN 0,0 m0/hr wa~, glv~1 m ~tit lon to Losahan Of 
to ~11 v~lL.mt~r~. Standing SBP and e~upm~ fof~.asm ~ d i ~  
measumm~ta w~m ewlua~ and I~mmto¢~ was ~ as em m~l  
of p~asma vokm~e, Measurem~t~ were ma~e ~t ~ e ,  3 ~u~ foeow~ 
acute TGTN and 1 week after therapy with the ~t ton  of L0ea~m On= 
ptaee:be) ~nd "rGTN. 
Reeutt~'/leutaly, TGTN c~,~ a fall in SBP m both gr0tq~, Fo~,a~g 
sustain~ TGTN therapy, SBP was uret~lged from baseline m bath 
(Lo88d~n: 117 ~ 11 vs 111 -t 15 m~Hg; Placebo: 11"/' ± 11 w 115 ~ 12 
mmHg). Tolerance also ~ to 1he forearm venous r e ~  and 
not prevente~l by Lo~rfan 
Pm YGI'N Post ~ta~ TGTN 
L~sanan 070 ± 020" 025 • 023" 
' p.  0 05 vemus pm.,SLGTN ~p ~ 001 versus I~e-TGTN 
Hemato~tt decreased after acute TGTN and remained s ign i~t ly  dl. 
minished folk~mg suslamed TGTN therapy in both groups. 
Conc/u~on: Therapy wffh an angmlensin n ~or  antagonist ~ not 
prevent he devalo~ment m tolerarce tO the hemodynam¢ and venous ~ 
of TGTN. 
[loo.:1 1 =, 
Fill ing ~ure  aml ~ma Hormones for 
Advanced Progressive Remodel ing ~ Effect of  
Quinapdl  
I. Kugler, P. Gaudron, K. Hu, W. Bauer, C. Eilles, G. ErtL 2 ~ Medica/Clinic, 
Un~ver~y of Heidelberg at Mannheim, Germany 
B a ~  Progressive left vehicular (LV) ralatmn after myeeardml m- 
farclmn (MI) and h~gh norepmephnne in LV dysfunction cam/an adverse 
pro~-~o.31s. Our hypotl'te~s was that pmvefll]on of repetitwe rise of filling 
pressure and of plasma homlones during ordinary dmly mmrcme may be 
,mportant for pmvan~on of fu~er remodeling alter mfamtlon. 
MeU~ods: 25 pa1~mts with pmgresswe remodeling ware randomized (dou- 
ble-blied) to placebo (P, n = 13) or qufnapnl (Q. 10-40 mojday, n = 12). At 
baseline and follow-up (1, 6 and 12 months (M)) LV end-diastolic volume 
index (EDV1. ml/rn 2, gated SPECT), h o ~  (ANP, RIA. RTml; Nore- 
p~nephnne, HPLC, Wml) and LV titling pressure at rest and dunng I~cycte 
exerose equwalent vo dairy ordinary acbvmes (Swan-Ganz-catheter) were 
measureD. 
Resu/ts: LV dilation continued on P (della EDVI 6 M: 9 ± 2.2; 12 M: 26 
± 2.2) but not on Q (b M: 0.1 ± 2.5, 12 M I ± 2.5). Rme of wedge p~e-~ure 
with exerose dld not differ at baseline (Q: 20 ± 2, P: 21 ± 3) but was lower 
on Q (17 ± 1") compared to P (24 ± 5) at 12 M. At rest NOR decreased in 
O (322 ± 37. 420 ± 58, 238 ± 42, 270 ± 29 t , rANOVA p < 0.05 ,,Is 1 M) 
but not on P (331 ± 44. 422 ± 61,235 ± 31,284 ± 54). Rise of NOR on 
ese~se .=t 12 mo~ths was alleviated by O (baseline: 776 ± 103. 12 M: 476 
± 81. p < 0.05) compared to baseline, not on P (has.ins: 742 ± 157, 12 M: 
498 ± 101, n.s.). 
Conclusion: Prevention of further remodeling by O may be due to affen- 
uation of exercme induced rise of filling pressure and of exerose induced 
neurohumoral activahon (mean ± SEM; "p < 0.05 vs P). Thus, reduction of 
repetitive nse of filling pressure dunng dally ordinary activity may be tmpertant 
for prevention of progression of LV dilation by quinapnL 
I 1004-1341 Recovery of Myocyte Hypert rophy and Slippage 
Associated With the Left Vsntrtcumr Remodeling 
of  Myocardial Hibernation 
T. Lai, L Me, W.-C. Wu. D. Knibbs. D. Waters. C. Chen. Hartford Ho,~piral. 
Hartford. Connechcut. USA 
We have previously shown that LV remodeling occurs in hibernating my. 
ocardium (HM), with wall thinning related to slipaage of my0cyte bundles and 
myocyle hypertrophy. To study whether repedusion reverses these cellular 
changes, we created a LAD stenosis to reduce flow by ~ 4~ m 5 p~gs. 
producing severe regional LV dysfunction. At 7 days LV bi~p.~i=s were taken 
from the hibernating and normal regions; then the stenoses were released 
to reperfuse the HM and pigs were kept alive tar 4 weeks for recover. Con- 
trois consisted of 4 sham-operated pigs without stenoses. The number of 
myocytes per mm thickness of LV walt was counted and expressed as cell 
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density, end myocyto width was measured with 400x on 1 Hm slides by light 
microscopy, Intorstlttnnl tissue w(]s expressed as % of total area, 
Results: The stonosis reduced moan LAD flow from 0,90 ± 0.12 to 0,55 
~: 0.12 ml/min/g nnd wall thickening from 38 :~- 3% to 10 "J: 6%. Alter 4 weeks 
of repeduston, wnnll thickening in HM reoovered to 28 ± 4%, Results el the 
mlcrosooplo study am presented In the t81ble: 
Conlrol Day 7 of 6tenonl~ Roporfu~lon 
Myocyta Den,lty 57 ;t 1 45 ~; 4' ~14 ± 3 
Myocyl~ wldlh (urn) 17,7 ~ 0,3 2P..2 :t~ P.,0' 182 ~ (],0 
Intcr~llti~l¢ontl~nt (%) 1~,0 ~: 0,2 17,8 ~ 2,3' t6,t .t, 1,4' 
'P ,~ 0,01 Compared to b~aol~ne 
Concluf~lon~: Reped(]slon of hlbern81ting my(]oardigm for 4 weeks restores 
myecyte number n(]mss th(] LV we111, Indlc81tlng recov(]ry in the armngomect 
ot myo(~yto bgndlee~ 81nd pmllal regression of rnyuwte hypedrophy, 
~ Increased Level t  and Thrombln  Cytok lne 
Generat ion In 8table Angina are Radu©e¢l by 
Aspir in,  A Randemlud ,Cont ro l led ,  Cro#l ,ovet  
'rdal 
I, Ikonomidls, F, Andmottl ~ , C, St8110nsdla, C, Pit,ayes, E, Eoonomou, 
P, "l'ogtogz818, E Nihoyannapo(]l(]s ~ , Ca~tology Ippocr~fian Hopif~l, Ath(]ns, 
GroPe: fH81mmot~mlfh Ho,~pifal Lonclon, UK 
~ckm¢~nd: Ro~enlty, the redu~tio, o! th(] ask tar myooardi811 Intamtion by as- 
pirin (ASA) h~s b(](]n attrlbuteed to its 81ntilnll~mm81tory p op(idle81 even when 
admlntst(]red P.f low doses. M~cmplt819(] colony 811tmu181ting factor (MCSF) 
causes m81crOphBg(]/monocyto acttv81tlon 81nd thus, release of vasoaotlve 
e(]bM81n~ms, intedeuklns lb (ILlb) and 6 ilL0) end tissue factor. Our aim was 
to tnvestlgst(] whether high cytoktne levi]Is 81nd Incm81sed thrombln goner. 
allen a) occur In stable angina (SA) b) are re181ted to transient myocardial 
tschaemla and c) 81m reduced by aspirin 
M~thocls: We measured prothrombln fragments (PF1 + 2, nmole/I) MCSF, 
ILl b, tL8 (pg/ml) plosmrt levels in 60 patients with SA and in 2 t he811thy centers 
by ELIS~, S81mplas were obtained at the 81nd o! a 46 h Halter monitoring (HM), 
All patients had anglogmphlcalty documented dlso81se and positive exemtso 
test. Fourty patients h81d isch81emla in HM and were randomly treated with 
ASA 300 rag, o.d, or placebo for 3 weeks in a double blind, erase-over trial. 
Melee(Is: PF1 + 2, MCSF, and IL6 were Increased in patients with SA 
comp81md to controls (table, p < 0,01), Analysis el variance showed that 
MCSF end ILlb increased according 1o the number of diseased (1-2-3) 
vessels (p - 0.05), Only MCSF was higher in patients with lschaemia in HM 
than those without (1124 ~ 651 vs 528 ~ 417, p -: 0.01). Although, PF1 + 2 
and cytokine levels wore decreasod by ASA (181bte, p - 0.05), they remained 
higher than those in controls (p ~ 0,05) 
~A ASA CONTROLS p 
PF1 * 2 226 t t 8 1 73 't 1 2 0.93 .t 0,5 -0.01 
MCSF 1076 t ~,13 950 t .567 479 t 207 .0.05 
IL0 4.2 ~: 1 3 3.5 "t 081 2.0 :t 0,9 • 0.05 
Conclusion: Elevated cytokine and PF1 + 2 plasma levels in SA sug- 
gest the presence of enhanced inflammatory activity and incre81sed threm- 
bin generation. Only MCSF was related to both extent of disease and 
daily life ischaemia. Reduction of the above factors by ASA may repre- 
sent an additional mechanism of its therapeutic action in coronanj artery 
disease. 
I 1004-136J  Estrogen and Progesterone Decrease Lipid 
Loading In Human Female Macrophages  
Jane A. McCrohen, Wondy Jessup, Shirley Nakhla, David S. Celermajer. 
The Heart Research Institute, Sydney, Australia 
Bac.=(grounc/: BaSed on the lower incidence of athereselerosis in females, we 
hypothesized that estrogen and progesterone may reduce lipid-loading in 
human macrophages (ie. foam cell formation). 
Methods: Monocytes from healthy female donors (n = 5) were plated out 
in phenol-red free RPMI and allowed to differentiate into macrophagos over 
10 days. Cells were treated from days 2-10 with either control media, 17 
-estradid (2 nM and 200 nM) ~ the estrogen receptor antagonist ICI 182 
780, diothylstilbestrol (DES, non-stereidal estrogen), 17~-estradiol (17.¢.E, 
inactive stereoisomer) or progesterone 10 nM. Lipid-loading was assessed 
by HPLC after a 48 hr incubation (days 8-10) with acetylated LDL in lipopro. 
tein-deficient human serum. Triplicate wells were used for each condition, in 
each experiment. 
Results: Macrophages treated with 17/~.estradiol showed a significant 
dose-related reduction in cholesterol ester formation vs controls (88 ± 12% 
and 78 ± 14% for 2nM end 200aM ostradiol respectively vs 100 ± 5%. 
p = 0.04 by ANOVA). Them was a similar trend in the levels of free and 
total cholesterol (p : 0,06). These effects worn not blocked by ICI 182 780, 
Progesterone alone (10 nM) was also associated with a marked redu(]tion in 
choloeter01 ester loading (16 ± 5%, p .~ 0,00 ;). In ooantrast, DES end 17..E 
did not reduce lipid loading, E81trogen exposure In male mecmphegea (n = 
4), showed no algnlfloant effect (89 :E 13%). 
Conclusion: 17p-estradlo181nd progesterone reduce lipid loading in human 
f(]m8110 mecrophegoa, consistent with en etheropretective effect, 
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• Improved Proe~lura l  Resu l ts  o f  Coronary  
........ 8 tent ing With Focal  Ba l loon  "Overoxpane lon"  -
Fine! Core Lab Analysis From the Prospect ive,  
Mult leenfer  OSTI-RA ~ la l  
G.W, Stone. S, Kiosk, S. B81iloy, I'. Sanbom, D. R(]berts, A Oshim~, 
E, Aldelman, P. Yeck, IF. St. Gck!l, T.J. Linnemeier. El Camino ~ra l ,  
Mountain Vmw, CA, USA 
The pnman/deferminant el 181re Outcome following corona w stealing m the 
rain, slant die+ (MSD) or rain. stant area (MSA) achieved. Slant expansion 
continues to increase as press(ire is raised from 12 to 18 arm. To study 
whether luminal dimensions can be safely further increased by using over. 
sized t)alloorls at high pressure, Patroaz-Schatz steals were implanted at 18 
arm. in 143 COnSecutive Isns in 120 pts at 7 centers. IVUS was pedonned. 
and it ~0.7 mrs of vessel remodeling was present at the lesion (external 
elastic membrane die. • ref. segment lumen die. ~:0.7 mm). the st0nt was 
further expanded with a balloon ._-0.5 mm larger at 16 atm. To minimize 
edge dissections found in prior trials of aggressive stealing, a novel focally 
expanding balloon was used which grows 0.5 mm larger centrally (within 
the slant) than outside the stent (the CVD FACT'=). QCA and IVUS were 
performed pro. pest standard stenting, and post focal stenting, and analyzed 
at independent core labs (Stanford). 
Results: By QCA, the baseline mean tel. dia. was 3.02 ± 0.48 mm and 
MLD was 1.10 ± 0.53 mm Remodeling was present to permit focal stent 
"overexpanston" in 120 of 143 lens (84%). 
slandaz'd slanting local slanting p value 
Mezzo balloon dta 336 ~ 037 3 87 ~ O 37 - O 0001 
Bai)oon-afto~ r~tlo 112 ~: (]17 1.33 -~ 020 - OOOOt 
MSD (turn). QCA 2.78 J: 0.43 2.93 x 0.44 -.0 0001 
MSO (rnm). IVUS 2.77 i Q39 2(]5 ~ 0.38 .00001 
MSA (rnm ~') - IVUS 7.29 ± 1 89 8.22 t 1 90 .00001 
By QCA, dissections were present at 4 stent edges after standard balloons 
and 1 slant edge alter focal upsizing, No pedorations, subacute thromboses 
or major ischomic complications occun'ed. 
Conclusions: Balloons traditionally considered ovemized, applied focally 
within the slant borders, may safely be used in the majority of lesions, and 
result in improved luminal dimensions. 
• I s  High Pressure Inflation Necessary for Optimal 
Stent ing? 
S. Elezi, A. Kastrati. J. Pache. J. Dirschinger, A. Sch~mig. 1. MedJzinische 
Klinik & Deutsches Herzzentrum, TU Munchen, Germany 
High pressure inflation after comnan/stent placement has been employed 
to achieve optimal stent deployment. However, it is not clear whether this 
is due to more radial tome generated by high pressure inflation o= simply 
by bigger balloon size. Quantitative angiograph¢c analysis we performed 
on 2724 lesions (2096 patients). The adequacy of stent deployment was 
based on pe, :eat diameter .~tenosis (DS) immediately after stent placement. 
Balloon to vessel ratio (BRD) and balloon pressure (BP) correlated with DS, 
but there was a much stronger correlation for BRD (r = -0.63 vs. r = -0.21, 
p < 0.001). When both BRD and BP were entered in a multivariate stepwise 
linear regression analysis (DS as a outcome variable), together with other 
factors, a significant independent role could be documented only for BRD (/~ 
= -0.641, p < 0.001). 
